- Home
- LDWY vs NURO Comparison
LDWY vs NURO Comparison
Compare LDWY & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDWY
- NURO
- Stock Information
- Founded
- LDWY 1990
- NURO 1996
- Country
- LDWY United States
- NURO United States
- Employees
- LDWY N/A
- NURO N/A
- Industry
- LDWY Advertising
- NURO Medical/Dental Instruments
- Sector
- LDWY Consumer Discretionary
- NURO Health Care
- Exchange
- LDWY Nasdaq
- NURO Nasdaq
- Market Cap
- LDWY 8.2M
- NURO 7.6M
- IPO Year
- LDWY 1991
- NURO N/A
- Fundamental
- Price
- LDWY $4.60
- NURO $4.05
- Analyst Decision
- LDWY
- NURO
- Analyst Count
- LDWY 0
- NURO 0
- Target Price
- LDWY N/A
- NURO N/A
- AVG Volume (30 Days)
- LDWY 6.1K
- NURO 28.9K
- Earning Date
- LDWY 11-19-2024
- NURO 02-20-2025
- Dividend Yield
- LDWY N/A
- NURO N/A
- EPS Growth
- LDWY N/A
- NURO N/A
- EPS
- LDWY N/A
- NURO N/A
- Revenue
- LDWY $31,581,000.00
- NURO $3,767,764.00
- Revenue This Year
- LDWY N/A
- NURO N/A
- Revenue Next Year
- LDWY N/A
- NURO N/A
- P/E Ratio
- LDWY N/A
- NURO N/A
- Revenue Growth
- LDWY N/A
- NURO N/A
- 52 Week Low
- LDWY $3.02
- NURO $2.66
- 52 Week High
- LDWY $6.88
- NURO $4.73
- Technical
- Relative Strength Index (RSI)
- LDWY 51.07
- NURO 54.09
- Support Level
- LDWY $4.38
- NURO $3.93
- Resistance Level
- LDWY $5.03
- NURO $4.13
- Average True Range (ATR)
- LDWY 0.19
- NURO 0.11
- MACD
- LDWY -0.04
- NURO 0.01
- Stochastic Oscillator
- LDWY 26.19
- NURO 70.37
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.